Ann L. MacDougall's Net Worth
$303 Thousand
Who is Ann L. MacDougall?
Ann L. MacDougall does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include OPIANT PHARMACEUTICALS, INC., and PROGENICS PHARMACEUTICALS INC.
SEC CIK
Ann L. MacDougall's CIK is 0001685788
Past Insider Trading and Trends
2018 was Ann L. MacDougall's most active year for acquiring shares with 27 total transactions. Ann L. MacDougall's most active month to acquire stocks was the month of May. 2021 was Ann L. MacDougall's most active year for disposing of shares, totalling 8 transactions. Ann L. MacDougall's most active month to dispose stocks was the month of February. 2021 saw Ann L. MacDougall paying a total of $233,340.00 for 27,834 shares, this is the most they've acquired in one year. In 2023 Ann L. MacDougall cashed out on 38,179 shares for a total of $563,580.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
OPIANT PHARMACEUTICALS, INC. No price found
InvestorAnn L. MacDougall used to own units in Common Stock but no longer holds any shares there. In the year 2016 Ann L. MacDougall filed a total of 15 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -28.18K |
$20.00 | -$563,580.00 |
0
|
Mar 2
| |||
Form 4
| +7.64% | 2K |
—
|
—
| 28.18K |
Jun 14
| |||
Form 4
| +12.94% | 3K |
$10.93 | $32,778.00 | 26.18K |
May 13
| |||
Form 4
| +9.44% | 2K |
—
|
—
| 23.18K |
Jun 15
| |||
Form 4
| +1.64% | 341 |
$10.00 | $3,410.00 | 21.18K |
May 13
| |||
Form 4
| +9.67% | 1.84K |
$10.68 | -$739.92 | 20.84K |
Mar 15 - Mar 17
| |||
Form 4
| +58.33% | 7K |
$10.00 | $70,000.00 | 19K |
Feb 11
| |||
Form 4
| +20.00% | 2K |
—
|
—
| 12K |
Jun 15
| |||
Form 4
| +100.00% | 5K |
$14.54 | $72,700.00 | 10K |
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
∞
| 5K |
$16.51 | $82,566.72 | 5K |
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PROGENICS PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||